• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • Webinars
  • Cisema Webinar – Rehabilitation Equipment Market in China and Hong Kong

Cisema Webinar – Rehabilitation Equipment Market in China and Hong Kong

Monday, 28 June 2021 / Published in Webinars

Cisema Webinar – Rehabilitation Equipment Market in China and Hong Kong

Cisema participated in the U.S. Commercial Service webinar on June 24, 2021, which provided an overview on China and Hong Kong’s rehabilitation healthcare market, market needs and sales opportunities, and explained how U.S. companies can enter these markets. Cisema experts Hamish King (COO) and Arthur Ng (BD North America) spoke about the regulatory requirements and registration pathway.

The webinar focused on China and Hong Kong’s rehabilitation equipment markets, both of which offer opportunities for foreign exporters. These markets are underdeveloped given current and future demand. The main sources of demand relate to postoperative rehabilitation of patients from the neurology, neurosurgery, orthopedics, pediatrics, gynecology and obstetrics, and cardiopulmonary departments.

China’s medical rehabilitation market is estimated to reach $14.4 billion in annual sales by 2023, with an annual compound growth rate of over 18 percent.

Upgrading China’s healthcare system is a government priority, spurred by population and healthcare realities. At the end of 2019, China registered 254 million people aged 60 and above, accounting for 18.1% of the total population. This demographic will reach 300 million by 2025. Chinese government data reveals 300 million patients with chronic disease and 30 million children aged 0-15 requiring rehabilitation. These realities drive the need for therapy equipment, daily living aids, mobility equipment, tele-rehabilitation services and body support devices.

Agenda

• USCS China Market Introduction, Aliza Totayo, Commercial Officer, Global Market, ITA

• China and Hong Kong Rehabilitation Market Briefing by William Zhang, Partner, Pricewaterhouse Coopers Management Consulting

• Market Access Briefing – Regulatory Requirements and Registration Pathway by Cisema (Hamish King COO and Arthur Ng, BD North America)

• Q&A

Tagged under: healthcare, rehabilitation equipment, US market

What you can read next

Cisema Webinars: How to Submit a Drug Master Filing (DMF) of API, Excipients & Packaging to China NMPA
Webinar: MedTech pathway to China: Market opportunities, regulatory hurdles and recent updates
Cisema Webinar with US’s AdvaMed: Opportunities and Regulatory Implications in China’s Digital Healthcare Economy

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.